Evolent Health, Inc. (EVH) SEC filings

EVHNYSEServices-Management ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value

$4.90+0.13 (+2.73%)

Close on Nov 13, 2026Market cap $553.99MP/E –Yield –

SEC filings

40 of Evolent Health's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jun 4, 2026	Jun 4, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 7, 2026	SEC EDGAR
Current report	8-K	May 7, 2026	May 7, 2026	SEC EDGAR
Proxy statement	DEF 14A	Jun 4, 2026	Apr 24, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Feb 25, 2026	SEC EDGAR
Current report	8-K	Feb 24, 2026	Feb 24, 2026	SEC EDGAR
Current report	8-K	Dec 5, 2025	Dec 8, 2025	SEC EDGAR
Current report	8-K	Dec 1, 2025	Dec 2, 2025	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 7, 2025	SEC EDGAR
Current report	8-K	Nov 6, 2025	Nov 6, 2025	SEC EDGAR
Current report	8-K	Sep 23, 2025	Sep 23, 2025	SEC EDGAR
Current report	8-K	Aug 18, 2025	Aug 21, 2025	SEC EDGAR
Current report	8-K	Aug 18, 2025	Aug 19, 2025	SEC EDGAR
Current report	8-K	Aug 18, 2025	Aug 18, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 11, 2025	SEC EDGAR
Current report	8-K	Aug 7, 2025	Aug 7, 2025	SEC EDGAR
Current report	8-K	Jun 19, 2025	Jun 20, 2025	SEC EDGAR
Current report	8-K	Jun 5, 2025	Jun 5, 2025	SEC EDGAR
Current report	8-K	Jun 3, 2025	Jun 3, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 9, 2025	SEC EDGAR
Current report	8-K	May 8, 2025	May 8, 2025	SEC EDGAR
Proxy statement	DEF 14A	Jun 5, 2025	Apr 25, 2025	SEC EDGAR
Current report	8-K	Apr 16, 2025	Apr 22, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Feb 21, 2025	SEC EDGAR
Current report	8-K	Feb 20, 2025	Feb 20, 2025	SEC EDGAR
Current report	8-K	Feb 3, 2025	Feb 4, 2025	SEC EDGAR
Current report	8-K	Jan 24, 2025	Jan 30, 2025	SEC EDGAR
Current report	8-K	Jan 13, 2025	Jan 13, 2025	SEC EDGAR
Current report	8-K	Dec 6, 2024	Dec 11, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 8, 2024	SEC EDGAR
Current report	8-K	Nov 7, 2024	Nov 7, 2024	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2024	Aug 9, 2024	SEC EDGAR
Current report	8-K	Aug 8, 2024	Aug 8, 2024	SEC EDGAR
Current report	8-K	Jun 6, 2024	Jun 11, 2024	SEC EDGAR
Current report	8-K	Jun 4, 2024	Jun 4, 2024	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2024	May 10, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Evolent Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVH.

Compare: EVH vs ASTH · EVH vs RTO · EVH vs HURN · EVH vs IT · EVH vs ICFI

Revenue growth14.1% · median 7.1%

Gross margin15.0% · median 35.6%

Operating margin-18.5% · median 9.2%

Net margin-21.7% · median 5.8%

Company	Revenue	Growth
IT	$6.46B	+0.7%
ASTH	$3.91B	+35.1%
EVH	$2.34B	+14.1%
ICFI	$1.83B	-5.2%
HURN	$1.81B	+13.6%
RTO	–	–

Company

Next earnings (est.): Feb 23, 2027, during market hours
Exchange: NYSE
Industry: Services-Management Services
Fiscal year ends: December 31
Employees: 4,200
Held by institutions: 99.3%
Auditor: Deloitte & Touche LLP
SEC CIK: 1628908

Advertisement
300 × 250

See a number that looks wrong?